FINWIRES · TerminalLIVE
FINWIRES

AsiaPhos Chief Risk Officer Passes Away

By

AsiaPhos' (SGX:5WV) chief risk officer and head of investor relations, Jaime Chiew Chi Loong, passed away on May 21, according to a Friday filing with the Singapore Exchange.

Loong had been serving as the company's chief risk officer and head of investor relations since September 2014.

Related Articles

Asia

Geo Energy Resources Issues, Allots Shares Under Share Option Scheme

Geo Energy Resources (SGX:RE4) issued 964,000 shares worth SG$32,400 under its share option scheme, according to a Tuesday filing with the Singapore Exchange.The new shares are expected to be listed and quoted on or around May 26, the filing said.

$SGX:RE4
Asia

TianYiMa Information Industry Forms Data JV

Guangdong TianYiMa Information Industry (SHE:301178) jointly established a data subsidiary with Shantou East Coast Investment Construction.Guangdong Tianyima Data Industry, with 10 million yuan in registered capital, will focus on data labeling and cross-border data processing, according to a Thursday filing with the Shenzhen bourse.The software company will hold a 80% stake, while Shantou East Coast Investment Construction will hold 20%.Guangdong TianYiMa Information Industry shares closed 5% higher Friday.

$SHE:301178
Asia

Sun Pharmaceutical Industries Consolidated Profit Grows in Fiscal Q4; Shares Slip 3

Sun Pharmaceutical Industries' (NSE:SUNPHARMA, BOM:524715) consolidated net profit increased to 27.1 billion Indian rupees in the fiscal fourth quarter ended March 31, from 21.5 billion rupees a year ago.Earnings per share climbed to 11.3 rupees from the year-ago figure of 9.0 rupees, according to a Friday filing to the Indian stock exchanges by the pharmaceutical company.Total revenue from operations in fiscal Q4 jumped to 146.1 billion rupees from 129.6 billion rupees a year earlier.The company's board declared a final dividend of 5 rupees per share for the financial year ended March 31.Sun Pharma's shares were down nearly 3% in recent trade.

$BOM:524715$NSE:SUNPHARMA